PTAB Decision Not To Sanction Bass Shifts Focus To Capitol
The Patent Trial and Appeal Board's decision not to sanction controversial hedge fund manager Kyle Bass for challenging drug patents in America Invents Act reviews clears the way for similar challenges,...To view the full article, register now.
Already a subscriber? Click here to view full article